Determination of lymph node metastasis using quantitative ultrasound elastography of papillary thyroid carcinoma nodule: a systematic review and meta-analysis.
IF 3.2 3区 医学Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Alisa Mohebbi, Saeed Mohammadzadeh, Mohammad Ghaffari, Afshin Mohammadi, Nathalie J Bureau, Ali Abbasian Ardakani
{"title":"Determination of lymph node metastasis using quantitative ultrasound elastography of papillary thyroid carcinoma nodule: a systematic review and meta-analysis.","authors":"Alisa Mohebbi, Saeed Mohammadzadeh, Mohammad Ghaffari, Afshin Mohammadi, Nathalie J Bureau, Ali Abbasian Ardakani","doi":"10.1186/s12880-025-01858-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>papillary thyroid carcinoma (PTC) as the most common thyroid tumor, tends to invade adjacent organs, especially lymphatic system. This study aimed to evaluate the discrimination performance of ultrasound elastography (USE) in assessing PTC nodule for determination of cervical lymph node metastasis (CLNM).</p><p><strong>Methods: </strong>The protocol was pre-registered at ( https://osf.io/r5tc8 ). Using PubMed, Web of Science, Embase, and Cochrane Library, studies published up to March 10, 2025, were identified. Data extraction was conducted independently, and a random-effects bivariate model was applied to estimate pooled differentiation accuracy estimates.</p><p><strong>Results: </strong>Twenty-one studies were included involving 7559 patients; 2790 (36%) were positive for CLNM, while 4769 (63%) were negative. The pooled E<sub>mean</sub> values for positive and negative CLNM were 51.2k Pa (95% CI: 42.6 to 59.7) and 44.8 kPa (95% CI: 35.2 to 54.4), respectively. It represents an absolute increase of 6.14 kPa (95% CI: 2.70 to 9.59) in the metastatic group compared to the benign group. Additionally, the pooled E<sub>max</sub> value for positive and negative CLNM were 87.9 kPa (95% CI: 49.5 to 126.4) and 68.7 kPa (95% CI: 44.2 to 93.1), respectively. This corresponds to an absolute increase of + 19.57 kPa (95% CI: 2.96 to 36.18) in the metastatic group, representing a more dramatic elevation compared to E<sub>mean</sub> values. The thyroid nodule E<sub>max</sub> and E<sub>mean</sub> were significantly higher for positive CLNM of + 27.5% (95% CI: 10.5-44.5%) and + 12.9% (95% CI: 5.1-20.7%) respectively. Combining USE with conventional ultrasound improved differentiation accuracy, achieving a sensitivity of 80% (95% CI: 62-90%), specificity of 79% (95% CI: 70-85%), and an AUC of 0.85 (95% CI: 0.81 to 0.88).</p><p><strong>Conclusion: </strong>USE parameters demonstrated potential as a discrimination tool for the preoperative assessment of CLNM, particularly when combined with conventional ultrasound, which enhances its performance.</p><p><strong>Clinical trial number: </strong>N/A.</p>","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":"25 1","pages":"342"},"PeriodicalIF":3.2000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12369039/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medical Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12880-025-01858-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Background and purpose: papillary thyroid carcinoma (PTC) as the most common thyroid tumor, tends to invade adjacent organs, especially lymphatic system. This study aimed to evaluate the discrimination performance of ultrasound elastography (USE) in assessing PTC nodule for determination of cervical lymph node metastasis (CLNM).
Methods: The protocol was pre-registered at ( https://osf.io/r5tc8 ). Using PubMed, Web of Science, Embase, and Cochrane Library, studies published up to March 10, 2025, were identified. Data extraction was conducted independently, and a random-effects bivariate model was applied to estimate pooled differentiation accuracy estimates.
Results: Twenty-one studies were included involving 7559 patients; 2790 (36%) were positive for CLNM, while 4769 (63%) were negative. The pooled Emean values for positive and negative CLNM were 51.2k Pa (95% CI: 42.6 to 59.7) and 44.8 kPa (95% CI: 35.2 to 54.4), respectively. It represents an absolute increase of 6.14 kPa (95% CI: 2.70 to 9.59) in the metastatic group compared to the benign group. Additionally, the pooled Emax value for positive and negative CLNM were 87.9 kPa (95% CI: 49.5 to 126.4) and 68.7 kPa (95% CI: 44.2 to 93.1), respectively. This corresponds to an absolute increase of + 19.57 kPa (95% CI: 2.96 to 36.18) in the metastatic group, representing a more dramatic elevation compared to Emean values. The thyroid nodule Emax and Emean were significantly higher for positive CLNM of + 27.5% (95% CI: 10.5-44.5%) and + 12.9% (95% CI: 5.1-20.7%) respectively. Combining USE with conventional ultrasound improved differentiation accuracy, achieving a sensitivity of 80% (95% CI: 62-90%), specificity of 79% (95% CI: 70-85%), and an AUC of 0.85 (95% CI: 0.81 to 0.88).
Conclusion: USE parameters demonstrated potential as a discrimination tool for the preoperative assessment of CLNM, particularly when combined with conventional ultrasound, which enhances its performance.
期刊介绍：
BMC Medical Imaging is an open access journal publishing original peer-reviewed research articles in the development, evaluation, and use of imaging techniques and image processing tools to diagnose and manage disease.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
